Quantitative Evaluation of Drug-Drug Interaction Potentials by in vivo Information- Guided Prediction Approach
作者： Feng Chen , Zhe-Yi Hu , Wei-Wei Jia , Jing-Tao Lu , Yuan-Sheng Zhao
DOI: 10.2174/1389200216666150223151758
关键词:
摘要: … CYP enzymes [25], as shown in Eq. 12 and 13. … inducer on the activity of the CYP enzymes involved in the drug interaction. Apparently, IX is similar to IR of inhibitors and IndR of inducers…
eurekaselect.com
researchgate.net 参考文章(30)
David J. Greenblatt, Introduction to Drug-Drug Interactions Drug Interactions in Infectious Diseases. pp. 1- 10 ,(2011) , 10.1007/978-1-61779-213-7_1
Yuansheng Zhao, Zhe-Yi Hu, Physiologically based pharmacokinetic modelling and in vivo [I]/Ki accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate British Journal of Pharmacology. ,vol. 171, pp. 1043- 1053 ,(2014) , 10.1111/BPH.12533
Michel Tod, Christina Nkoud-Mongo, François Gueyffier, Impact of Genetic Polymorphism on Drug-Drug Interactions Mediated by Cytochromes: A General Approach The AAPS Journal. ,vol. 15, pp. 1242- 1252 ,(2013) , 10.1208/S12248-013-9530-2
Michel Tod, Sylvain Goutelle, Fannie Clavel-Grabit, Grégoire Nicolas, Bruno Charpiat, Quantitative prediction of cytochrome P450 (CYP) 2D6-mediated drug interactions. Clinical Pharmacokinectics. ,vol. 50, pp. 519- 530 ,(2011) , 10.2165/11592620-000000000-00000
Motohiro Kato, Yoshihisa Shitara, Hitoshi Sato, Kunihiro Yoshisue, Masaru Hirano, Toshihiko Ikeda, Yuichi Sugiyama, The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling. Pharmaceutical Research. ,vol. 25, pp. 1891- 1901 ,(2008) , 10.1007/S11095-008-9607-2
K Yoshida, K Maeda, Y Sugiyama, Transporter-mediated drug--drug interactions involving OATP substrates: predictions based on in vitro inhibition studies. Clinical Pharmacology & Therapeutics. ,vol. 91, pp. 1053- 1064 ,(2012) , 10.1038/CLPT.2011.351
Darko Butina, Matthew D Segall, Katrina Frankcombe, Predicting ADME properties in silico: methods and models Drug Discovery Today. ,vol. 7, pp. S83- S88 ,(2002) , 10.1016/S1359-6446(02)02288-2
Matthew G. Hudelson, Nikhil S. Ketkar, Lawrence B. Holder, Timothy J. Carlson, Chi-Chi Peng, Benjamin J. Waldher, Jeffrey P. Jones, High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods. Journal of Medicinal Chemistry. ,vol. 51, pp. 648- 654 ,(2008) , 10.1021/JM701130Z
Akihiro Hisaka, Yoshiyuki Ohno, Takehito Yamamoto, Hiroshi Suzuki, Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information Pharmacology & Therapeutics. ,vol. 125, pp. 230- 248 ,(2010) , 10.1016/J.PHARMTHERA.2009.10.011
Kuresh A. Youdim, Aref Zayed, Maurice Dickins, Alex Phipps, Michelle Griffiths, Amanda Darekar, Ruth Hyland, Odette Fahmi, Susan Hurst, David R. Plowchalk, Jack Cook, Feng Guo, R. Scott Obach, Application of CYP3A4 in vitro data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction British Journal of Clinical Pharmacology. ,vol. 65, pp. 680- 692 ,(2008) , 10.1111/J.1365-2125.2007.03070.X